BRPI0820341A2 - bactéria mycoplasma viva, atenuada, composição de vacina e métodod para identificar clones de mycoplasma atenuados - Google Patents

bactéria mycoplasma viva, atenuada, composição de vacina e métodod para identificar clones de mycoplasma atenuados Download PDF

Info

Publication number: BRPI0820341A2
Authority: BR; Brazil
Prior art keywords: attenuated mycoplasma; live; vaccine composition; clones; identifying
Prior art date: 2007-11-06

Application number

BRPI0820341A

Other languages

English (en)

Inventor

Chu Hsien-Jue

Rae Gibson Nicole

Li Wumin

Xu Zhichang

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-06

Filing date

2008-11-05

Publication date

2020-05-19

2008-11-05 Application filed by Wyeth Llc filed Critical Wyeth Llc

2020-05-19 Publication of BRPI0820341A2 publication Critical patent/BRPI0820341A2/pt

2021-11-09 Publication of BRPI0820341B1 publication Critical patent/BRPI0820341B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0820341-5A 2007-11-06 2008-11-05 Composição imunogênica para uso na proteção de um animal contra uma doença associada a uma cepa virulenta de mycoplasma hyopneumoniae BRPI0820341B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US98581107P	2007-11-06	2007-11-06
US60/985,811		2007-11-06
PCT/US2008/082454 WO2009061798A1 (en)	2007-11-06	2008-11-05	Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine

Publications (2)

Publication Number	Publication Date
BRPI0820341A2 true BRPI0820341A2 (pt)	2020-05-19
BRPI0820341B1 BRPI0820341B1 (pt)	2021-11-09

Family

ID=40303616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820341-5A BRPI0820341B1 (pt)	2007-11-06	2008-11-05	Composição imunogênica para uso na proteção de um animal contra uma doença associada a uma cepa virulenta de mycoplasma hyopneumoniae

Country Status (20)

Country	Link
US (1)	US9056909B2 (pt)
EP (1)	EP2217271B1 (pt)
JP (1)	JP5869221B2 (pt)
KR (1)	KR101225304B1 (pt)
CN (2)	CN104043116A (pt)
AR (1)	AR069216A1 (pt)
AU (1)	AU2008324780A1 (pt)
BR (1)	BRPI0820341B1 (pt)
CA (1)	CA2704775C (pt)
CL (1)	CL2008003304A1 (pt)
CO (1)	CO6270337A2 (pt)
DK (1)	DK2217271T3 (pt)
HK (1)	HK1198289A1 (pt)
ME (1)	ME01000B (pt)
MX (1)	MX2010005014A (pt)
RU (1)	RU2489164C9 (pt)
TW (1)	TWI513463B (pt)
UA (1)	UA98812C2 (pt)
WO (1)	WO2009061798A1 (pt)
ZA (1)	ZA201004026B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
US8444989B1 (en) *	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
KR101734590B1 (ko) *	2009-05-19	2017-05-11	바이오프로퍼티스 피티와이 엘티디	마이코플라스마　하이오뉴모니에의 온도 감수성 백신 균주 및 그의 용도
US9260691B2 (en) *	2010-05-19	2016-02-16	Bioproperties Pty Ltd	Methods relating to an attenuated mycoplasma
CN102988978B (zh) *	2011-08-01	2016-02-03	普莱柯生物工程股份有限公司	含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
CN103083658B (zh) *	2011-10-27	2015-09-02	普莱柯生物工程股份有限公司	一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
CN103157100B (zh) *	2011-12-08	2014-09-24	普莱柯生物工程股份有限公司	副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法
CN103157104B (zh) *	2011-12-14	2015-11-18	普莱柯生物工程股份有限公司	猪瘟疫苗的硫代硫酸钠稀释液
CA2866199A1 (en)	2012-03-07	2013-09-12	Ceva Sante Animale	Novel veterinary vaccine
UA114504C2 (uk) *	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
EP2684959A1 (en) *	2012-07-10	2014-01-15	Laboratorios Hipra, S.A.	Vectors for transforming Mycoplasma hyopneumoniae, transformed M.hyopneumoniae strains, and use thereof
CN104685057B (zh) *	2012-07-10	2019-04-16	海博莱科学有限公司	用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
CN103623400B (zh) *	2012-08-24	2016-08-17	普莱柯生物工程股份有限公司	抗猪支原体肺炎、传染性胸膜肺炎疫苗组合物及制备方法
CN103861095B (zh) *	2012-12-11	2016-03-09	普莱柯生物工程股份有限公司	含猪支原体肺炎抗原和猪链球菌病抗原的疫苗组合物及其制备方法和应用
KR102153275B1 (ko) *	2012-12-28	2020-09-09	베링거잉겔하임베트메디카게엠베하	마이코플라스마 백신의 제조 방법
CN104981252B (zh)	2012-12-28	2019-06-18	勃林格殷格翰动物保健有限公司	包含支原体抗原的免疫原性组合物
WO2014182872A1 (en)	2013-05-08	2014-11-13	Protatek International, Inc.	Vaccine for pcv2 and mycoplasma
CN104338128B (zh) *	2013-07-31	2017-09-05	普莱柯生物工程股份有限公司	一种疫苗组合物及其制备方法和应用
US20160199482A1 (en) *	2013-09-05	2016-07-14	Zoetis Services Llc	Hendra and nipah virus g glycoprotein immunogenic compositions
CN104248759B (zh) *	2013-11-19	2017-05-10	普莱柯生物工程股份有限公司	一种疫苗组合物及其制备方法和应用
KR20160099223A (ko) *	2015-02-12	2016-08-22	강원대학교산학협력단	마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10279031B2 (en) *	2016-05-11	2019-05-07	Phibro Animal Health Corporation	Composition comprising antigens and a mucosal adjuvant and a method for using
KR101846478B1 (ko) *	2016-08-12	2018-04-06	주식회사 이노백	재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물
CN109234418B (zh) *	2018-11-20	2021-08-13	湖南中净生物科技有限公司	一种鉴别猪肺炎支原体野毒株和疫苗株的引物、试剂盒和方法
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN112143666B (zh) *	2020-09-07	2023-02-21	华中农业大学	一种猪肺炎支原体弱毒株及其在制备弱毒疫苗中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3917619A (en)	1972-03-06	1975-11-04	Bayer Ag	2-Amino-4,5-dihydropyridine derivatives
JPS5540568B2 (pt) *	1972-10-05	1980-10-18
US4567043A (en)	1983-06-15	1986-01-28	American Home Products Corporation (Del.)	Canine corona virus vaccine
FR2565825B1 (fr)	1984-06-15	1990-07-13	Centre Nat Rech Scient	Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4894332A (en)	1985-03-27	1990-01-16	Biogen, Inc.	DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
JPS62273456A (ja)	1986-05-21	1987-11-27	Tosoh Corp	分析装置用に用いるテストカツプのシ−ル箔破開用シ−ルブレ−カ
JPH0795069B2 (ja) *	1986-05-22	1995-10-11	農林水産省家畜衛生試験場長	マウスＩｇＡ単クローン抗体を用いる豚マイコプラズマ肺炎の診断方法
EP0283840A3 (en)	1987-03-26	1989-08-09	Ml Technology Ventures, L.P.	Mycoplasma hyopneumoniae antigen and uses therefor
US5565205A (en)	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0571648A1 (en)	1992-05-26	1993-12-01	Chung-Nan Weng	Vaccine protecting against mycoplasmal pneumonia
BE1008978A5 (fr) *	1994-12-27	1996-10-01	Solvay	Adjuvants pour vaccins.
GB9622159D0 (en)	1996-10-24	1996-12-18	Solvay Sociutu Anonyme	Polyanionic polymers as adjuvants for mucosal immunization
ZA9710606B (en) *	1996-12-05	1998-06-12	Akzo Nobel Nv	Non-virulent Mycoplasma synoviae vaccine thereof.
WO2001034189A2 (en)	1999-11-08	2001-05-17	Biomune	Vaccines for mycoplasma bovis and methods of use
US6585981B1 (en)	2000-07-27	2003-07-01	Regents Of The University Of Minnesota	Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
MY129765A (en)	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
PT2027873E (pt)	2001-07-02	2015-11-03	Zoetis Services Llc	Vacinação de dose única com mycoplasma hyopneumoniae
BR0211049A (pt)	2001-07-02	2004-07-20	Pfizer Prod Inc	Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
AU2002365244B2 (en) *	2001-07-27	2007-12-06	Zoetis Services Llc	West nile vaccine
US20030129161A1 (en)	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en)	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
AU2003221791A1 (en) *	2002-04-05	2003-10-27	Iowa State University Research Foundation, Inc.	Mycoplasma polypeptides
TWI350174B (en)	2003-03-12	2011-10-11	Wyeth Corp	Adjuvanted bovine vaccines
RU2278704C2 (ru) *	2004-01-12	2006-06-27	Алексей Борисович Башкиров	Метод индукции иммунного ответа организма млекопитающих-2

2008
- 2008-11-05 KR KR1020107012323A patent/KR101225304B1/ko active IP Right Grant
- 2008-11-05 CN CN201410277325.4A patent/CN104043116A/zh active Pending
- 2008-11-05 AU AU2008324780A patent/AU2008324780A1/en not_active Abandoned
- 2008-11-05 US US12/265,274 patent/US9056909B2/en active Active
- 2008-11-05 DK DK08847411.9T patent/DK2217271T3/en active
- 2008-11-05 CN CN2008801185417A patent/CN101883581A/zh active Pending
- 2008-11-05 JP JP2010533203A patent/JP5869221B2/ja active Active
- 2008-11-05 EP EP08847411.9A patent/EP2217271B1/en active Active
- 2008-11-05 UA UAA201005344A patent/UA98812C2/ru unknown
- 2008-11-05 BR BRPI0820341-5A patent/BRPI0820341B1/pt active IP Right Grant
- 2008-11-05 MX MX2010005014A patent/MX2010005014A/es active IP Right Grant
- 2008-11-05 ME MEP-2010-78A patent/ME01000B/me unknown
- 2008-11-05 CA CA2704775A patent/CA2704775C/en active Active
- 2008-11-05 RU RU2010117614/15A patent/RU2489164C9/ru active
- 2008-11-05 WO PCT/US2008/082454 patent/WO2009061798A1/en active Application Filing
- 2008-11-06 AR ARP080104863A patent/AR069216A1/es not_active Application Discontinuation
- 2008-11-06 CL CL2008003304A patent/CL2008003304A1/es unknown
- 2008-11-06 TW TW097142888A patent/TWI513463B/zh active
2010
- 2010-05-06 CO CO10054267A patent/CO6270337A2/es not_active Application Discontinuation
- 2010-06-04 ZA ZA2010/04026A patent/ZA201004026B/en unknown
2014
- 2014-11-21 HK HK14111806.5A patent/HK1198289A1/xx unknown

Also Published As

Publication number	Publication date
KR20100087202A (ko)	2010-08-03
DK2217271T3 (en)	2016-06-06
TW200927166A (en)	2009-07-01
CL2008003304A1 (es)	2009-01-09
EP2217271B1 (en)	2016-05-04
RU2489164C2 (ru)	2013-08-10
CN101883581A (zh)	2010-11-10
RU2010117614A (ru)	2011-12-20
UA98812C2 (ru)	2012-06-25
CA2704775C (en)	2016-05-10
ME01000B (me)	2012-10-20
TWI513463B (zh)	2015-12-21
WO2009061798A1 (en)	2009-05-14
HK1198289A1 (en)	2015-03-27
AR069216A1 (es)	2010-01-06
EP2217271A1 (en)	2010-08-18
CO6270337A2 (es)	2011-04-20
JP5869221B2 (ja)	2016-02-24
BRPI0820341B1 (pt)	2021-11-09
JP2011503086A (ja)	2011-01-27
CN104043116A (zh)	2014-09-17
AU2008324780A1 (en)	2009-05-14
RU2489164C9 (ru)	2014-01-20
US9056909B2 (en)	2015-06-16
ZA201004026B (en)	2011-04-28
KR101225304B1 (ko)	2013-01-22
US20090117152A1 (en)	2009-05-07
MX2010005014A (es)	2010-06-30
CA2704775A1 (en)	2009-05-14

Publication	Publication Date	Title
BRPI0820341A2 (pt)	2020-05-19	bactéria mycoplasma viva, atenuada, composição de vacina e métodod para identificar clones de mycoplasma atenuados
BRPI0907438A2 (pt)	2015-08-04	Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
BRPI0815841A2 (pt)	2015-09-01	Métodos e composições para melhoramento de traços preferidos.
HK1217168A1 (zh)	2016-12-30	用於活的減毒病毒的方法和組合物
BRPI0812446A2 (pt)	2014-10-14	Métodos para aperfeiçoamento de propriedades de proteína múltiplas
BRPI0922046A2 (pt)	2019-09-24	dispositivo de reprodução, método de reprodução e programa para reprodução estereoscópica
BR112013006155A2 (pt)	2016-06-07	aparelho trocador de calor, e, método para inibir formação de um condensado
BRPI0916756A2 (pt)	2019-09-24	sistemas e métodos para anestesiar o tecido auricular.
BRPI0807918A2 (pt)	2017-05-16	composições e método para preservação de tecido
BRPI0919575A2 (pt)	2017-03-28	método, e, composição
BRPI0916788A2 (pt)	2018-03-20	sistema e método para gerenciamento de rede
BRPI0923315A2 (pt)	2019-09-24	método sistema e utilização para comutação de calor.
BRPI1015336A2 (pt)	2018-02-20	composições para tratamento de tecidos que compreendem polímeros de organossiloxano
BRPI0716439A2 (pt)	2013-09-17	formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI0810024A2 (pt)	2014-10-14	Composição floculante, método de floculação, e, polímero contendo silício
BRPI0809573A2 (pt)	2016-07-26	composição, e, método
BRPI0823277A2 (pt)	2015-06-23	Composição, e , método
BRPI0815057A2 (pt)	2015-07-28	Composto, composição farmacêutica, e, método para tratar infecção.
BRPI0817334A2 (pt)	2015-03-24	Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados
BRPI1007929A2 (pt)	2015-09-01	"métodos e composições para o tratamento de neovascularização".
HUE048893T2 (hu)	2020-08-28	Fûtõ és hûtõhálózat épületek számára
BRPI0814167A2 (pt)	2015-01-20	Composição, e, método
ZA201002515B (en)	2010-12-29	Live attenuated mycoplasma strains
BRPI0810865A2 (pt)	2017-05-09	antígenos de tripanossoma, composições vacinais, e métodos relacionados
BRPI0911252A2 (pt)	2015-10-06	método, extrato, e, composição.

Legal Events

Date	Code	Title	Description
2020-06-02	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-07-14	B25A	Requested transfer of rights approved	Owner name: PAH W LLC (US)
2020-07-28	B25D	Requested change of name of applicant approved	Owner name: ZOETIS W LLC (US)
2020-08-11	B25A	Requested transfer of rights approved	Owner name: ZOETIS SERVICES LLC (US)
2020-09-01	B25G	Requested change of headquarter approved	Owner name: ZOETIS SERVICES LLC (US)
2021-01-19	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-05-25	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-09-14	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-11-09	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/11/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.